| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 18,480,882 | 12,438,237 | 11,403,042 | | Cost of Revenue | 7,156,047 | 4,394,341 | 4,178,404 | | | Gross Profit | 11,324,835 | 8,043,896 | 7,224,638 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 1,721,226 | 285,969 | 212,950 | | Non Recurring | 226,132 | 1,098,503 | 570,931 | | Others | 1,475,459 | 1,014,544 | 888,838 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 7,902,018 | 5,644,881 | 5,551,919 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 539,425 | (202,893) | 144,261 | | Earnings Before Interest And Taxes | 8,496,326 | 5,952,036 | 5,696,179 | | Interest Expense | 5,288 | 14,150 | 7,226 | | Income Before Tax | 8,491,038 | 5,937,886 | 5,688,954 | | Income Tax Expense | 1,981,188 | 1,652,373 | 1,701,473 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 6,509,850 | 3,874,045 | 3,987,480 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 6,509,850 | 3,874,045 | 3,987,480 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $6,509,850 | $3,874,045 | $3,987,480 |
|
1.48% Nasdaq 
Income Statement
